Richard P. Junghans

Richard P. Junghans

Associate Professor of Medicine


MD, University of Miami

PhD, University of California, Berkley

General field of research:

Immunology; Oncology; Gene Therapy

Affiliations other than medicine:

Evans Center for Interdisciplinary Biomedical Research

Roger Williams Medical Center Director, Biotherapeutics Development Lab

Contact information:

825 Chalkstone Avenue Providence, RI 02908


T cells Immunotherapy; Gene Therapy

Summary of research interest:

Richard P. Junghans, Ph.D., M.D., Associate Professor of Medicine, Boston University School of Medicine, is Director, Biotherapeutics Development Lab (BDL).  Dr. Junghans brings dual backgrounds in basic science and clinical medicine to a research program in clinical translational research.  He obtained his MD (U Miami) and training in Internal Medicine (Georgetown) and Hematology-Oncology (NCI/NIH), where he trained in immunology with Dr Thomas Waldmann, and his Ph.D. in Molecular Biology (UC Berkeley) in which his thesis described activities of retrovirus reverse transcriptases.

He applies molecular engineering techniques to develop new immunotherapies to treat cancer and infectious diseases, and is a rec0gnized leader in the field of cancer gene therapy.  He has completed Institutional Review Board applications, initiated Phase I and Phase II human clinical trials, secured FDA Investigational New Drug (IND) status for antibody and gene therapy agents and previously established an on-campus facility for gene therapy applications.  Dr. Junghans has more than 70 publications.  He is Board Certified in Internal Medicine and Medical Oncology and Board Eligible in Hematology.